Skip to content

Alpha stage software — under active development. Data may be incomplete or change without notice.

FolioFact
FolioFact
Q2 2026 58/68 funds filed
Latest observation
Sign in Sign up

Some record dates are in the future and are excluded from the latest observation date.

Stock overview

Candel Therapeutics, Inc.

Explore the company, reported ownership, price history, and available source evidence.

Candel Therapeutics, Inc. (CADL) is a healthcare or biotechnology equity security tracked from 13F filings.

CADL · USD

Price

Market closed No stored price observations

Price history unavailable

No completed price observation is stored for this share class yet. Try a longer range to view available daily closes.

Investor Popularity

Latest reported institutional positions from SEC 13F filings.

0 holders

No tracked fund's latest available 13F reports CADL.

This state describes the stored filings; it does not imply a current position.

SEC Forms 4/5

Insiders

Reported trades

SEC fundamentals

Financials

Companyfacts

Official-source analysis

AI Earnings Report

View all AI Earnings Reports

No published AI Earnings Report yet

We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.

Options market

Options

IV30 · daily

Send feedback

Optional — tap one if it fits

We'll only use this to respond to your feedback.